Anna Gregor

3.2k total citations · 1 hit paper
27 papers, 2.2k citations indexed

About

Anna Gregor is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Anna Gregor has authored 27 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 8 papers in Genetics. Recurrent topics in Anna Gregor's work include Lung Cancer Research Studies (9 papers), Glioma Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Anna Gregor is often cited by papers focused on Lung Cancer Research Studies (9 papers), Glioma Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Anna Gregor collaborates with scholars based in United Kingdom, United States and Belgium. Anna Gregor's co-authors include Richard Stephens, Hiroshi Ueoka, Henry Wagner, C. Le Péchoux, Anne Aupérin, R. Arriagada, Paul E.G. Kristjansen, Bruce E. Johnson, Jean‐Pierre Pignon and Joseph Aisner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Anna Gregor

27 papers receiving 2.2k citations

Hit Papers

Prophylactic Cranial Irradiation for Patients with Small-... 1999 2026 2008 2017 1999 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Gregor United Kingdom 15 1.5k 1.3k 893 479 292 27 2.2k
Stephanie E. Weiss United States 22 699 0.5× 987 0.8× 326 0.4× 709 1.5× 164 0.6× 64 1.7k
J. Kirk Martin United States 25 907 0.6× 609 0.5× 377 0.4× 83 0.2× 786 2.7× 48 1.7k
Adele Caldarella Italy 25 499 0.3× 374 0.3× 346 0.4× 285 0.6× 287 1.0× 71 1.6k
Hongqing Zhuang China 24 553 0.4× 769 0.6× 214 0.2× 229 0.5× 250 0.9× 97 1.7k
Nimish Mohile United States 22 599 0.4× 489 0.4× 217 0.2× 1000 2.1× 115 0.4× 89 1.8k
Daniela Greto Italy 22 571 0.4× 797 0.6× 180 0.2× 295 0.6× 319 1.1× 126 1.8k
L. Chauveinc France 20 241 0.2× 877 0.7× 203 0.2× 413 0.9× 280 1.0× 65 1.6k
Monika Hackl Austria 18 1.0k 0.7× 636 0.5× 464 0.5× 325 0.7× 150 0.5× 40 1.7k
M Hansen Denmark 20 1.1k 0.7× 641 0.5× 513 0.6× 55 0.1× 117 0.4× 40 1.5k
Roland Guttenberger Germany 16 249 0.2× 434 0.3× 155 0.2× 467 1.0× 186 0.6× 37 1.3k

Countries citing papers authored by Anna Gregor

Since Specialization
Citations

This map shows the geographic impact of Anna Gregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gregor more than expected).

Fields of papers citing papers by Anna Gregor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gregor. The network helps show where Anna Gregor may publish in the future.

Co-authorship network of co-authors of Anna Gregor

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gregor. A scholar is included among the top collaborators of Anna Gregor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gregor. Anna Gregor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stanaszek, Luiza, Anna Gregor, & Teresa Zalewska. (2011). Regulation of neurogenesis by extracellular matrix and integrins. Acta Neurobiologiae Experimentalis. 71(1). 103–112. 40 indexed citations
2.
Erridge, Sara, Diane Stockton, Mark W. J. Strachan, et al.. (2009). Radiotherapy for pituitary adenomas: Long-term efficacy and toxicity. Radiotherapy and Oncology. 93(3). 597–601. 76 indexed citations
3.
Mead, Graham M., Norman M. Bleehen, Anna Gregor, et al.. (2000). A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma. Cancer. 89(6). 1359–1370. 129 indexed citations
5.
Aupérin, Anne, R. Arriagada, Jean‐Pierre Pignon, et al.. (1999). Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission. New England Journal of Medicine. 341(7). 476–484. 1155 indexed citations breakdown →
6.
Pignon, T., Anna Gregor, C. Koning, et al.. (1998). Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiotherapy and Oncology. 46(3). 239–248. 86 indexed citations
7.
Ellis, Richard & Anna Gregor. (1998). The treatment of brain metastases from lung cancer. Lung Cancer. 20(2). 81–84. 11 indexed citations
8.
Signorini, David F., et al.. (1998). Significant change in tests of neurological impairment in patients with brain tumours. Journal of Neuro-Oncology. 39(1). 81–90. 14 indexed citations
9.
Postmus, Pieter E., Hanny Haaxma-Reiche, Anna Gregor, et al.. (1998). Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiotherapy and Oncology. 46(1). 29–32. 68 indexed citations
10.
Gaze, Mark N., Charles Kelly, G.R. Kerr, et al.. (1997). Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiotherapy and Oncology. 45(2). 109–116. 201 indexed citations
11.
Grant, Robert A., James Slattery, Anna Gregor, & Ian R. Whittle. (1994). Recording neurological impairment in clinical trials of glioma. Journal of Neuro-Oncology. 19(1). 37–49. 45 indexed citations
12.
Gregor, Anna, R. Rampling, Matti Aapro, et al.. (1992). Phase II study of tauromustine in malignant glioma. European Journal of Cancer. 28(12). 1959–1962. 17 indexed citations
13.
Denholm, S. W., et al.. (1991). Management of patients aged over 60 years with supratentorial glioma: Lessons from an audit. Surgical Neurology. 36(2). 106–111. 50 indexed citations
14.
Coleman, Robert E., Robert Leonard, M A Cornbleet, et al.. (1991). The late results of consolidation treatment following induction chemotherapy for small cell lung cancer. Lung Cancer. 7(5). 299–307. 2 indexed citations
15.
Gregor, Anna. (1991). Controversies in the treatment of non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. 27(3). 362–366. 13 indexed citations
16.
Hardman, P.D.J., Jeanne E. Bell, Ian R. Whittle, & Anna Gregor. (1989). Familial Glioma: A report of glioblastoma in identical twins and oligo-astrocytoma in siblings. British Journal of Neurosurgery. 3(6). 709–715. 7 indexed citations
17.
Gregor, Anna. (1989). CNS toxicity: Report for IASLC workshop — June 1989. Lung Cancer. 5(4-6). 275–280. 3 indexed citations
18.
Wheldon, T. E., I. Berry, Joseph A. O’Donoghue, et al.. (1987). The effect on human neuroblastoma spheroids of fractionated radiation regimes calculated to be equivalent for damage to late responding normal tissues. European Journal of Cancer and Clinical Oncology. 23(6). 855–860. 6 indexed citations
19.
Gregor, Anna, et al.. (1984). Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemotherapy and Pharmacology. 13(2). 106–8. 23 indexed citations
20.
Gregor, Anna, et al.. (1980). Comparison of dietary histories in lung cancer cases and controls with special reference to vitamin A. Nutrition and Cancer. 2(2). 93–97. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026